↓ Skip to main content

Early exposure to the combined measles–mumps–rubella vaccine and thimerosal-containing vaccines and risk of autism spectrum disorder

Overview of attention for article published in Vaccine, January 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
14 news outlets
blogs
8 blogs
twitter
232 X users
peer_reviews
1 peer review site
facebook
80 Facebook pages
wikipedia
3 Wikipedia pages
googleplus
3 Google+ users
reddit
5 Redditors
video
1 YouTube creator

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
254 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Early exposure to the combined measles–mumps–rubella vaccine and thimerosal-containing vaccines and risk of autism spectrum disorder
Published in
Vaccine, January 2015
DOI 10.1016/j.vaccine.2014.12.036
Pubmed ID
Authors

Yota Uno, Tokio Uchiyama, Michiko Kurosawa, Branko Aleksic, Norio Ozaki

Abstract

This case-control study investigated the relationship between the risk of Autism Spectrum Disorder (ASD) onset, and early exposure to the combined Measles-Mumps-Rubella (MMR) vaccine and thimerosal consumption measured from vaccinations in the highly genetically homogenous Japanese population.

X Demographics

X Demographics

The data shown below were collected from the profiles of 232 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 254 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Italy 1 <1%
Germany 1 <1%
Canada 1 <1%
Unknown 250 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 64 25%
Student > Master 41 16%
Researcher 29 11%
Other 18 7%
Student > Ph. D. Student 16 6%
Other 49 19%
Unknown 37 15%
Readers by discipline Count As %
Medicine and Dentistry 60 24%
Psychology 31 12%
Biochemistry, Genetics and Molecular Biology 21 8%
Nursing and Health Professions 20 8%
Agricultural and Biological Sciences 16 6%
Other 61 24%
Unknown 45 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 351. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2024.
All research outputs
#93,849
of 25,746,891 outputs
Outputs from Vaccine
#128
of 16,620 outputs
Outputs of similar age
#913
of 361,639 outputs
Outputs of similar age from Vaccine
#2
of 143 outputs
Altmetric has tracked 25,746,891 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,620 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,639 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 143 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.